Antimicrobial Viewpoints

About
Experts
Webinars & Conferences
Antimicrobial Viewpoints
Resources
JOIN US
My account
- Logout

You are here:Home-Antimicrobial Viewpoints

Find a Viewpoint

Search for:

<br>Strengthening the regulation of antimicrobial use to mitigate drug resistance</br><em> – by Maarten van der Heijden</em> — Strengthening the regulation of antimicrobial use to mitigate drug resistance – by Maarten van der Heijden
16 July 2021

<br>Addressing the knowledge gaps surrounding AMR infections in neonatal sepsis</br><em> – by Phoebe Williams, Nina Putri and Gayana Gunaratna</em> — Addressing the knowledge gaps surrounding AMR infections in neonatal sepsis – by Phoebe Williams, Nina Putri and Gayana Gunaratna
17 June 2021

<br>Rapid diagnostic tests to support clinical trials of antibiotics</br><em> – by Gian Maria Rossolini</em> — Rapid diagnostic tests to support clinical trials of antibiotics – by Gian Maria Rossolini
2 June 2021

<br>Will new antibiotic classes solve multidrug resistance?</br><em> – by Michael N. Dudley and Olga Lomovskaya</em> — Will new antibiotic classes solve multidrug resistance? – by Michael N. Dudley and Olga Lomovskaya
21 May 2021

<br>Introducing ProMED-AMR, the new ProMED network for antimicrobial resistance</br><em> – by Matthew E. Levison</em> — Introducing ProMED-AMR, the new ProMED network for antimicrobial resistance – by Matthew E. Levison
26 April 2021

<br>Causes of antibiotic shortages and the solutions to address them</br><em> – by Enrico Baraldi</em> — Causes of antibiotic shortages and the solutions to address them – by Enrico Baraldi
10 February 2021

<br>Monitoring antimicrobial resistance in Ghana: a focus on the hospital environment</br><em> – by Abiola Isawumi and Lydia Mosi</em> — Monitoring antimicrobial resistance in Ghana: a focus on the hospital environment – by Abiola Isawumi and Lydia Mosi
18 January 2021

<br>Learning from IPC strategies for COVID-19 to mitigate AMR in rural Nigerian communities</br><em> – by Rachael Osagie</em> — Learning from IPC strategies for COVID-19 to mitigate AMR in rural Nigerian communities – by Rachael Osagie
9 December 2020

<br>The antibiotic R&D landscape in Japan</br><em> – by Norio Ohmagari</em> — The antibiotic R&D landscape in Japan – by Norio Ohmagari
25 November 2020

<br>Tackling the drug-resistance pandemic – 2020 and beyond</br><em> – by Laura J.V. Piddock</em> — Tackling the drug-resistance pandemic – 2020 and beyond – by Laura J.V. Piddock
23 November 2020

<br>Why are new antibacterials failing as commercial products?</br><em> – by Patricia A. Bradford</em> — Why are new antibacterials failing as commercial products? – by Patricia A. Bradford
19 November 2020

<br>COVID-19: Coinfection, secondary bacterial infections and AMR in India</br><em> – by Venkatasubramanian Ramasubramanian</em> — COVID-19: Coinfection, secondary bacterial infections and AMR in India – by Venkatasubramanian Ramasubramanian
12 November 2020

1
2
3
4
Next »

Share

Facebook Twitter Reddit LinkedIn Email

REVIVE

REVIVE is a space for everybody with an interest in antimicrobial R&D.

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization developing new treatments for drug-resistant infections that pose the greatest threat to health. We were created to ensure that everyone who needs antibiotics receives effective and affordable treatment, no matter where they live. We aim to develop five new treatments by 2025 to fight drug-resistant infections, focusing on sexually transmitted infections, sepsis in newborns and infections in hospitalized adults and children.

Content

Antimicrobial Viewpoints (40)
Conferences recordings (18)
Experts (142)
External webinars (19)
Uncategorized (2)
Webinars (44)

Search site

Search for:

CONNECT

Twitter
LinkedIn
YouTube

GARDP
DNDi

Privacy Policy | Terms of Use | Acceptable Use Policy | Cookie Policy

We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser.
Read our cookie policy